Literature DB >> 7849263

Negative transcriptional regulation by nuclear receptors.

F Saatcioglu1, F X Claret, M Karin.   

Abstract

Steroid and thyroid hormones, and vitamins A and D bind to nuclear receptors, which act as ligand-modulated transcription factors. In many cases, ligand-activated nuclear receptor binds to positively acting hormone response elements (p-HREs) to induce gene transcription. However, ligand-activated receptors also repress transcription of specific genes and several mechanisms that account for negative regulation have recently emerged. One major form of negative regulation is based on transcriptional interference between nuclear receptors and other transcription factors, such as AP-1. In this case, the liganded receptor prevents AP-1 or other positively acting transcription factors from fruitful interaction with the transcription initiation complex. A second form of negative regulation is based on binding of nuclear receptors to specialized negative HREs (n-HREs). Binding of unliganded receptor to such an element results in constitutive activation, which is terminated by the binding of ligand. While transcriptional interference with AP-1 has been described for many members of the nuclear receptor family, negative regulation through n-HREs so far has been shown only for one of the thyroid hormone receptors. However, this type of negative regulation is likely to be widespread.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849263

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  20 in total

1.  Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

Authors:  C B Kallen; M A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  A cautionary note as to the use of pBi-L and related luciferase/transgenic vectors in the study of thyroid endocrinology.

Authors:  Ivan H Chan; Alexander D Borowsky; Martin L Privalsky
Journal:  Thyroid       Date:  2008-06       Impact factor: 6.568

3.  Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.

Authors:  S H Hong; C W Wong; M L Privalsky
Journal:  Mol Endocrinol       Date:  1998-08

4.  Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription.

Authors:  E J Schwarz; M J Reginato; D Shao; S L Krakow; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2.

Authors:  X Cheng; M J Reginato; N C Andrews; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 6.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

Authors:  D J Schroen; C E Brinckerhoff
Journal:  Gene Expr       Date:  1996

7.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

Authors:  G Bunone; P A Briand; R J Miksicek; D Picard
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

8.  Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1.

Authors:  Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-07-23

9.  A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.

Authors:  F X Claret; T Antakly; M Karin; F Saatcioglu
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

10.  Novel transcription coactivator complex containing activating signal cointegrator 1.

Authors:  Dong-Ju Jung; Hee-Sook Sung; Young-Wha Goo; Hyun Mi Lee; Ok Ku Park; Sung-Yun Jung; Janghoo Lim; Han-Jong Kim; Soo-Kyung Lee; Tae Sung Kim; Jae Woon Lee; Young Chul Lee
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.